Forte Biosciences
FBRX
57 hedge funds and large institutions have $65.6M invested in Forte Biosciences in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 6 reducing their positions, and 7 closing their positions.
367% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 6
186% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 7
30% more funds holding
Funds holding: 44 → 57 (+13)
0.01% less ownership
Funds ownership: 0.1% → 0.09% (-0.01%)
22% less call options, than puts
Call options by funds: $331K | Put options by funds: $425K
27% less capital invested
Capital invested by funds: $90.3M → $65.6M (-$24.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.04M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.25M |
| 3 |
AG
Artal Group
Luxembourg
|
+$1.07M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$1.07M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$978K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18.7M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$5.39M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$3.13M |
| 4 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$1.54M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$623K |
FBRX Hedge Fund Activity: Q4 2017 in Review
57 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q4 2017, worth a combined $65.6M — down 27% from $90.3M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new FBRX positions and 7 closed out — a net gain of 13 holders — while 28 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock, adding an estimated $3.04M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $18.7M sold.
- 57 institutional investors held Forte Biosciences (FBRX) as of Q4 2017, up from 44 in Q3 2017.
- Funds reported $65.6M of Forte Biosciences stock for Q4 2017, down 27% quarter-over-quarter.
- 20 funds opened new Forte Biosciences positions in Q4 2017 and 7 closed out, a net change of +13 holders.
- The largest Forte Biosciences buyer in Q4 2017 was BlackRock, an estimated $3.04M added.
- The largest Forte Biosciences seller in Q4 2017 was EcoR1 Capital, an estimated $18.7M sold.
Based on aggregated 13F filings for Q4 2017.